All Stories

Eli Lilly inks duo of deals, teaming with AdvanCell, OliX to push deeper into radiopharma, MASH

Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big Pharma is coughing up cash to work with them on radiopharmaceuticals and metabolic-associated steatohepatitis, respectively.

Feb 10, 2025 - 16:07
 0
Eli Lilly inks duo of deals, teaming with AdvanCell, OliX to push deeper into radiopharma, MASH
Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big Pharma is coughing up cash to work with them on radiopharmaceuticals and metabolic-associated steatohepatitis, respectively.
Read More

Tags:

Previous Article

American Airlines Resumes In-Flight Credit Card Announcements After Fatal Milita...

Next Article

Tariffs raise concern among generic drugmakers, as advocacy groups seek exemptions

Related Posts

Deputy director of FDA's CBER departs amid mass exodus at federal health agencies

Deputy director of FDA's CBER departs amid mass exodus ...

Feb 22, 2025  0

German research institute teams up with Barbados to improve cardiometabolic treatments for Black individuals

German research institute teams up with Barbados to imp...

Feb 20, 2025  0

Procedural ‘loophole’ leaves NIH grants frozen, despite orders from federal judge: reports

Procedural ‘loophole’ leaves NIH grants frozen, despite...

Feb 21, 2025  0